Business
MoreLocal Business
MoreFeatured Regional Business
MoreFeatured Perspectives on Business
MoreFeatured Reuters
MoreAstraZeneca to buy Fusion Pharma for $2 billion in cash
(Reuters) - AstraZeneca said on Tuesday it has agreed to buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals Inc for about $2 billion in cash. The drugmaker will pay $21 per Fusion share plus a non-transferable contingent value ...
Updated 3 minutes ago
|1 min read